Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | APEX1 | P27695 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.42 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17033938 | 0.99 | TDP1 (0.51) | TDP1POLBAPEX1HTTLMNA | |
| SCHEMBL17033926 | 0.96 | THRB (0.51) | TDP1POLBAPEX1HTTLMNA | |
| SCHEMBL17037023 | 0.96 | THRB (0.51) | TDP1POLBAPEX1HTTLMNA | |
| SCHEMBL17033927 | 0.96 | TDP1 (0.56) | TDP1POLBAPEX1HTTLMNA | |
| SCHEMBL15385973 | 0.94 | TDP1 (0.52) | TDP1POLBAPEX1HTTLMNA | |
| SCHEMBL17033940 | 0.94 | TDP1 (0.55) | TDP1POLBAPEX1HTTLMNA | |
| SCHEMBL17037024 | 0.93 | TDP1 (0.58) | TDP1POLBAPEX1HTTTHRB | |
| SCHEMBL65346 | 0.91 | TDP1 (0.52) | TDP1POLBAPEX1HTTLMNA | |
| SCHEMBL17036931 | 0.90 | TDP1 (0.49) | TDP1POLBAPEX1HTTLMNA | |
| SCHEMBL17033936 | 0.90 | TDP1 (0.63) | TDP1POLBAPEX1HTTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9844493-B2 | Adhesive bonding composition and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-12-19 | — | — | US | disclosed |
| US-20170065495-A1 | ADHESIVE BONDING COMPOSITION AND USE THEREOF | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2017-03-09 | — | — | US | disclosed |
| WO-2015126865-A1 | ADHESIVE BONDING COMPOSITION AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-08-27 | — | — | WO | disclosed |
| WO-2015126862-A1 | DENTAL COMPOSITION AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-08-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170065495-A1 | ADHESIVE BONDING COMPOSITION AND USE THEREOF | ICAM1, TAS2R42, CDH1 | TDP1 2012/4885POLB 1224/4885APEX1 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.